Source:http://linkedlifedata.com/resource/pubmed/id/11726227
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0019185,
umls-concept:C0034790,
umls-concept:C0042769,
umls-concept:C0085358,
umls-concept:C0271510,
umls-concept:C1332714,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1512948,
umls-concept:C1548610,
umls-concept:C1706438,
umls-concept:C1879547,
umls-concept:C2004454,
umls-concept:C2698600
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-11-29
|
pubmed:abstractText |
Mouse hepatitis virus (MHV) provides an excellent animal model for the study of the immunopathological mechanisms involved in hepatic viral diseases. We previously generated an attenuated viral variant, YAC-MHV3, which induces a subclinical disease and recovery within 15 days. In contrast, the L2-MHV3 strain induces the development of a fulminant hepatitis, leading to death within 3 days. In this paper, we document intrahepatic and splenic T cell subpopulations involved in the hepatitis process and viral elimination identified in attenuated or pathogenic MHV3-infected C57BL/6 mice. Percentages of intrahepatic CD4(+) cells decreased in attenuated YAC-MHV3-infected mice, while they increased in mice infected with pathogenic L2-MHV3, compared with uninfected animals. Moreover, in YAC-MHV3-infected mice, the percentages of intrahepatic CD8(+) cells slightly decreased at 24 h pi, then increased until 15 days pi. In contrast, the CD4/CD8 ratios of splenic lymphoid subpopulations increased in the first days of infection and returned to normal values at 15 days pi. Intrahepatic NK1.1(+)alphabeta - TCR(inter) cells decreased in both virally infected groups of mice, while CD4(+)alphabeta - TCR(inter) LFA-1(high) cells increased in L2-MHV3-infected mice, in contrast with what was seen in YAC-MHV3-infected mice. However, these cells became anergic following Con A or PHA stimulation. Ex vivo studies showed that only the intrahepatic CD8(+) cells that were increased in YAC-MHV3-infected mice could be stimulated by lectins. In addition, in vitro viral infections revealed that L2-MHV3 viral infection led to an increase of intrahepatic CD4(+)alphabeta - TCR(inter) cells in the absence of CD8(+) cells only. These results indicate that the attenuated phenotype of the YAC-MHV3 virus is related to two different mechanisms: the first involves no increase of intrahepatic CD4(+)alphabeta - TCR(inter) or NK-T cells, while the second favors the recruitment and activation of CD8(+) cells in liver. The results are discussed in relation to the integrity of intrahepatic immune tolerance mechanisms and immune-mediated viral elimination.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1521-6616
|
pubmed:author | |
pubmed:copyrightInfo |
(c)2001 Elsevier Science.
|
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11726227-Animals,
pubmed-meshheading:11726227-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11726227-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11726227-Cell Differentiation,
pubmed-meshheading:11726227-Coronavirus Infections,
pubmed-meshheading:11726227-Hepatitis, Viral, Animal,
pubmed-meshheading:11726227-Immune Tolerance,
pubmed-meshheading:11726227-Killer Cells, Natural,
pubmed-meshheading:11726227-Liver,
pubmed-meshheading:11726227-Mice,
pubmed-meshheading:11726227-Mice, Inbred C57BL,
pubmed-meshheading:11726227-Murine hepatitis virus,
pubmed-meshheading:11726227-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:11726227-Spleen
|
pubmed:year |
2001
|
pubmed:articleTitle |
Recovery from mouse hepatitis virus infection depends on recruitment of CD8(+) cells rather than activation of intrahepatic CD4(+)alphabeta(-)TCR(inter) or NK-T cells.
|
pubmed:affiliation |
Département des Sciences Biologiques, Université du Québec à Montréal, Montréal, H3C 3P8, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|